{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T18:20:28Z","timestamp":1774117228213,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T00:00:00Z","timestamp":1638489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T00:00:00Z","timestamp":1638489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["102912"],"award-info":[{"award-number":["102912"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s40121-021-00574-9","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T03:02:36Z","timestamp":1638500556000},"page":"351-365","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Short-Term Immunogenicity Profiles and Predictors for Suboptimal Immune Responses in Patients with End-Stage Kidney Disease Immunized with Inactivated SARS-CoV-2 Vaccine"],"prefix":"10.1007","volume":"11","clinical-trial-number":[{"clinical-trial-number":"tctr20210226002","registry":"10.18810\/tctr"}],"author":[{"given":"Sarinya","family":"Boongird","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyatida","family":"Chuengsaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chavachol","family":"Setthaudom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arkom","family":"Nongnuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montira","family":"Assanatham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salinnart","family":"Phanprasert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rungthiwa","family":"Kitpermkiat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasisopin","family":"Kiertiburanakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumthorn","family":"Malathum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angsana","family":"Phuphuakrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0930-8936","authenticated-orcid":false,"given":"Jackrapong","family":"Bruminhent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,3]]},"reference":[{"issue":"7821","key":"574_CR1","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430\u20136. https:\/\/doi.org\/10.1038\/s41586-020-2521-4.","journal-title":"Nature"},{"issue":"6","key":"574_CR2","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.kint.2020.09.006","volume":"98","author":"KJ Jager","year":"2020","unstructured":"Jager KJ, Kramer A, Chesnaye NC, et al. Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe. Kidney Int. 2020;98(6):1540\u20138.","journal-title":"Kidney Int"},{"issue":"9","key":"574_CR3","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.ekir.2021.06.027","volume":"6","author":"EJ Carr","year":"2021","unstructured":"Carr EJ, Kronbichler A, Graham-Brown M, et al. Review of early immune response to SARS-CoV-2 vaccination among patients with CKD. Kidney Int Rep. 2021;6(9):2292\u2013304. https:\/\/doi.org\/10.1016\/j.ekir.2021.06.027.","journal-title":"Kidney Int Rep"},{"issue":"6","key":"574_CR4","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.kint.2021.04.006","volume":"99","author":"NB Yanay","year":"2021","unstructured":"Yanay NB, Freiman S, Shapira M, et al. Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients. Kidney Int. 2021;99(6):1496\u20138. https:\/\/doi.org\/10.1016\/j.kint.2021.04.006.","journal-title":"Kidney Int"},{"key":"574_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100178","volume":"9","author":"J Stumpf","year":"2021","unstructured":"Stumpf J, Siepmann T, Lindner T, et al. Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: a prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine. Lancet Reg Health Eur. 2021;9: 100178. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100178.","journal-title":"Lancet Reg Health Eur"},{"issue":"8","key":"574_CR6","doi-asserted-by":"publisher","first-page":"1173.e1","DOI":"10.1016\/j.cmi.2021.04.028","volume":"27","author":"B Rozen-Zvi","year":"2021","unstructured":"Rozen-Zvi B, Yahav D, Agur T, et al. Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study. Clin Microbiol Infect. 2021;27(8):1173.e1-1173.e4. https:\/\/doi.org\/10.1016\/j.cmi.2021.04.028.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"574_CR7","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1093\/ndt\/gfab193","volume":"36","author":"N Longlune","year":"2021","unstructured":"Longlune N, Nogier MB, Miedouge M, et al. High immunogenicity of a messenger RNA-based vaccine against SARS-CoV-2 in chronic dialysis patients. Nephrol Dial Transplant. 2021;36(9):1704\u20139. https:\/\/doi.org\/10.1093\/ndt\/gfab193.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"574_CR8","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.2215\/CJN.03500321","volume":"16","author":"A Grupper","year":"2021","unstructured":"Grupper A, Sharon N, Finn T, et al. Humoral response to the Pfizer BNT162b2 vaccine in patients undergoing maintenance hemodialysis. Clin J Am Soc Nephrol. 2021;16(7):1037. https:\/\/doi.org\/10.2215\/CJN.03500321.","journal-title":"Clin J Am Soc Nephrol"},{"key":"574_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab155","author":"T Agur","year":"2021","unstructured":"Agur T, Ben-Dor N, Goldman S, et al. Antibody response to mRNA SARS-CoV-2 vaccine among dialysis patients\u2014a prospectivecohort study. Nephrol Dial Transplant. 2021. https:\/\/doi.org\/10.1093\/ndt\/gfab155.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"574_CR10","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.kint.2021.08.007","volume":"100","author":"S Boongird","year":"2021","unstructured":"Boongird S, Chuengsaman P, Phanprasert S, et al. Anti-SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report. Kidney Int. 2021;100(5):1136\u20138. https:\/\/doi.org\/10.1016\/j.kint.2021.08.007.","journal-title":"Kidney Int"},{"issue":"6","key":"574_CR11","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1053\/j.ajkd.2003.08.019","volume":"42","author":"G DaRoza","year":"2003","unstructured":"DaRoza G, Loewen A, Djurdjev O, et al. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better. Am J Kidney Dis. 2003;42(6):1184\u201392. https:\/\/doi.org\/10.1053\/j.ajkd.2003.08.019.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"574_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000443416","volume":"41","author":"J Eiselt","year":"2016","unstructured":"Eiselt J, Kielberger L, Rajdl D, Racek J, Pazdiora P, Mal\u00e1nov\u00e1 L. Previous vaccination and age are more important predictors of immune response to influenza vaccine than inflammation and iron status in dialysis patients. Kidney Blood Press Res. 2016;41(2):139\u201347. https:\/\/doi.org\/10.1159\/000443416.","journal-title":"Kidney Blood Press Res"},{"issue":"2","key":"574_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227719","volume":"15","author":"A Nongnuch","year":"2020","unstructured":"Nongnuch A, Ngampongpan W, Srichatrapimuk S, et al. Immune response to influenza vaccination in ESRD patients undergoing hemodialysis vs. hemodiafiltration. PLoS ONE. 2020;15(2): e0227719. https:\/\/doi.org\/10.1371\/journal.pone.0227719.","journal-title":"PLoS ONE"},{"key":"574_CR14","unstructured":"Abbott Core Laboratory. Abbott Architect i SARS-CoV-2 IgG II Quant Reagent Instructions for Use. 2012. https:\/\/www.corelaboratory.abbott\/int\/en\/offerings\/segments\/infectious-disease\/sars-cov-2. Accessed 30 Sep 2021."},{"issue":"9","key":"574_CR15","doi-asserted-by":"publisher","first-page":"1256.e9","DOI":"10.1016\/j.cmi.2020.05.036","volume":"26","author":"KL Chew","year":"2020","unstructured":"Chew KL, Tan SS, Saw S, et al. Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection. Clin Microbiol Infect. 2020;26(9):1256.e9-1256.e11. https:\/\/doi.org\/10.1016\/j.cmi.2020.05.036.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"574_CR16","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/s41587-020-0631-z","volume":"38","author":"CW Tan","year":"2020","unstructured":"Tan CW, Chia WN, Qin X, et al. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2\u2013spike protein\u2013protein interaction. Nat Biotechnol. 2020;38(9):1073\u20138. https:\/\/doi.org\/10.1038\/s41587-020-0631-z.","journal-title":"Nat Biotechnol"},{"key":"574_CR17","unstructured":"Coronavirus diagnostics by Euroimmun. SARS-CoV-2 NeutraLISA. https:\/\/www.coronavirus-diagnostics.com\/documents\/Indications\/Infections\/Coronavirus\/EI_2606_D_UK_F.pdf. Accessed 7 Sep 2021."},{"issue":"5","key":"574_CR18","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41590-021-00902-8","volume":"22","author":"J Zuo","year":"2021","unstructured":"Zuo J, Dowell AC, Pearce H, et al. Robust SARS-CoV-2-specific T\u00a0cell immunity is maintained at 6 months following primary infection. Nat Immunol. 2021;22(5):620\u20136. https:\/\/doi.org\/10.1038\/s41590-021-00902-8.","journal-title":"Nat Immunol"},{"issue":"4","key":"574_CR19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1053\/j.ajkd.2021.06.002","volume":"78","author":"JJ Broseta","year":"2021","unstructured":"Broseta JJ, Rodr\u00edguez-Espinosa D, Rodr\u00edguez N, et al. Humoral and cellular responses to mRNA-1273 and BNT162b2 SARS-CoV-2 vaccines administered to hemodialysis patients. Am J Kidney Dis. 2021;78(4):571\u201381. https:\/\/doi.org\/10.1053\/j.ajkd.2021.06.002.","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"574_CR20","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.2215\/CJN.03700321","volume":"16","author":"C Speer","year":"2021","unstructured":"Speer C, Goth D, Benning L, et al. Early humoral responses of hemodialysis patients after COVID-19 vaccination with BNT162b2. Clin J Am Soc Nephrol. 2021;16(7):1073\u201382. https:\/\/doi.org\/10.2215\/CJN.03700321.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"574_CR21","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","volume":"27","author":"DS Khoury","year":"2021","unstructured":"Khoury DS, Cromer D, Reynaldi A, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021;27(7):1205\u201311. https:\/\/doi.org\/10.1038\/s41591-021-01377-8.","journal-title":"Nat Med"},{"issue":"7871","key":"574_CR22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41586-021-03777-9","volume":"596","author":"D Planas","year":"2021","unstructured":"Planas D, Veyer D, Baidaliuk A, et al. Reduced sensitivity of SARS-CoV-2 variant delta to antibody neutralization. Nature. 2021;596(7871):276\u201380. https:\/\/doi.org\/10.1038\/s41586-021-03777-9.","journal-title":"Nature"},{"issue":"10305","key":"574_CR23","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/S0140-6736(21)01854-7","volume":"398","author":"EJ Carr","year":"2021","unstructured":"Carr EJ, Wu M, Harvey R, et al. Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients. Lancet. 2021;398(10305):1038\u201341. https:\/\/doi.org\/10.1016\/S0140-6736(21)01854-7.","journal-title":"Lancet"},{"issue":"10292","key":"574_CR24","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1016\/s0140-6736(21)01290-3","volume":"397","author":"EC Wall","year":"2021","unstructured":"Wall EC, Wu M, Harvey R, et al. Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination. Lancet. 2021;397(10292):2331\u20133. https:\/\/doi.org\/10.1016\/s0140-6736(21)01290-3.","journal-title":"Lancet"},{"issue":"10296","key":"574_CR25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/s0140-6736(21)01462-8","volume":"398","author":"EC Wall","year":"2021","unstructured":"Wall EC, Wu M, Harvey R, et al. AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC. Lancet. 2021;398(10296):207\u20139. https:\/\/doi.org\/10.1016\/s0140-6736(21)01462-8.","journal-title":"Lancet"},{"issue":"5","key":"574_CR26","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.chom.2013.04.010","volume":"13","author":"EC James","year":"2013","unstructured":"James EC, Eric PS. Iron in infection and immunity. Cell Host Microbe. 2013;13(5):509\u201319. https:\/\/doi.org\/10.1016\/j.chom.2013.04.010.","journal-title":"Cell Host Microbe"},{"issue":"9","key":"574_CR27","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1681\/ASN.2021040480","volume":"32","author":"D Bertrand","year":"2021","unstructured":"Bertrand D, Hamzaoui M, Lem\u00e9e V, et al. Antibody and T\u00a0cell response to SARS-CoV-2 messenger RNA BNT162b2 vaccine in kidney transplant recipients and hemodialysis patients. J Am Soc Nephrol. 2021;32(9):2147. https:\/\/doi.org\/10.1681\/ASN.2021040480.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"574_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2020.115294","volume":"99","author":"EJ Valcourt","year":"2021","unstructured":"Valcourt EJ, Manguiat K, Robinson A, et al. Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Diagn Microbiol Infect Dis. 2021;99(4): 115294. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115294.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"574_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.690698","volume":"12","author":"E Schrezenmeier","year":"2021","unstructured":"Schrezenmeier E, Bergfeld L, Hillus D, et al. Immunogenicity of COVID-19 Tozinameran vaccination in patients on chronic dialysis. Front Immunol. 2021;12: 690698. https:\/\/doi.org\/10.3389\/fimmu.2021.690698.","journal-title":"Front Immunol"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-021-00574-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-021-00574-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-021-00574-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T17:42:42Z","timestamp":1644946962000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-021-00574-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,3]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["574"],"URL":"https:\/\/doi.org\/10.1007\/s40121-021-00574-9","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,3]]},"assertion":[{"value":"29 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}